Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-16

FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for NebuPent (pentamidine isethionate) by Fresenius Kabi USA, LLC, to modify the existing approval for this inhalati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEBUPENT (Pentamidine isethionate)

Snippet

SUPPL AP for NEBUPENT (PENTAMIDINE ISETHIONATE)